ArticlePharmaceutics2024

Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic Impairment.

Mohammed S Alasmari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.